Form 4 for XBIT XBiotech Inc.
Accepted 2021-10-01 00:00:00 ET · period of report 2021-09-28 · accession 0001209191-21-058475 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-10-01 | 2021-09-28+ | XBIT | SIMARD JOHN | CEO, Dir, 10% | S - Sale | $13.34 | -60.9K | 4.03M | -1% | -$812.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-29 | S | D | 16,396 | $13.41 | 4,049,307 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 2 | Common | Common Stock | 2021-10-01 | S | D | 19,684 | $13.23 | 4,011,065 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 3 | Common | Common Stock | 2021-09-28 | S | D | 6,263 | $14.27 | 4,065,703 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 4 | Common | Common Stock | 2021-09-30 | S | D | 18,558 | $13.07 | 4,030,749 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |